Ptc Therapeutics, Inc. Earnings logo

PTCT

Ptc Therapeutics, Inc. Earnings

$50.14

Earnings Summary

Revenue
$1176.1Mn
Net Profits
$866.56Mn
Net Profit Margins
73.68%
PE Ratio
7.71
Highlights
Revenue:

Ptc Therapeutics, Inc.’s revenue jumped 459.73% since last year same period to $1176.1Mn in the Q1 2025. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated 451.71% jump in its revenue since last 3-months.

Net Profits:

Ptc Therapeutics, Inc.’s net profit jumped 1046.28% since last year same period to $866.56Mn in the Q1 2025. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated 1415.24% jump in its net profits since last 3-months.

Net Profit Margins:

Ptc Therapeutics, Inc.’s net profit margin jumped 269.06% since last year same period to 73.68% in the Q1 2025. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated 338.39% jump in its net profit margins since last 3-months.

PE Ratio:

Ptc Therapeutics, Inc.’s price-to-earnings ratio after this Q1 2025 earnings stands at 7.71.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Ptc Therapeutics, Inc. post its latest quarter earnings
EPS Estimate Current Quarter
-0.71
EPS Estimate Current Year
-0.71
Highlights
EPS Estimate Current Quarter:

Ptc Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.71 - a -8.46% fall from last quarter’s estimates.

EPS Estimate Current Year:

Ptc Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.71.

Key Ratios

Key ratios of the Ptc Therapeutics, Inc. post its Q1 2025 earnings
Earning Per Share (EPS)
10.04
Return on Assets (ROA)
0.24
Return on Equity (ROE)
-77.4
Highlights
Earning Per Share (EPS):

Ptc Therapeutics, Inc.’s earning per share (EPS) jumped 936.67% since last year same period to 10.04 in the Q1 2025. This indicates that the Ptc Therapeutics, Inc. has generated 936.67% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Ptc Therapeutics, Inc.’s return on assets (ROA) stands at 0.24.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Ptc Therapeutics, Inc.’s return on equity (ROE) stands at -77.4.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2025-05-06
-0.71
10.04
1524.11%

Discover More Earning Stocks in Health Technology Sector